Saba Capital Management’s The Oncology Institute TOI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $193K | Hold |
94,264
| – | – | ﹤0.01% | 198 |
|
|
2025
Q1 | $107K | Hold |
94,264
| – | – | ﹤0.01% | 159 |
|
|
2024
Q4 | $29.1K | Hold |
94,264
| – | – | ﹤0.01% | 207 |
|
|
2024
Q3 | $30.8K | Hold |
94,264
| – | – | ﹤0.01% | 228 |
|
|
2024
Q2 | $43.4K | Hold |
94,264
| – | – | ﹤0.01% | 239 |
|
|
2024
Q1 | $149K | Hold |
94,264
| – | – | ﹤0.01% | 190 |
|
|
2023
Q4 | $192K | Hold |
94,264
| – | – | ﹤0.01% | 238 |
|
|
2023
Q3 | $132K | Sell |
94,264
-76,114
| -45% | -$107K | ﹤0.01% | 283 |
|
|
2023
Q2 | $93.7K | Sell |
170,378
-4,135
| -2% | -$2.28K | ﹤0.01% | 347 |
|
|
2023
Q1 | $118K | Hold |
174,513
| – | – | ﹤0.01% | 432 |
|
|
2022
Q4 | $288K | Sell |
174,513
-173,546
| -50% | -$286K | ﹤0.01% | 534 |
|
|
2022
Q3 | $1.61M | Sell |
348,059
-19,233
| -5% | -$89.1K | 0.02% | 622 |
|
|
2022
Q2 | $1.86M | Sell |
367,292
-32,708
| -8% | -$165K | 0.02% | 642 |
|
|
2022
Q1 | $2.85M | Hold |
400,000
| – | – | 0.04% | 524 |
|
|
2021
Q4 | $3.73M | Buy |
400,000
+304,315
| +318% | +$2.84M | 0.06% | 422 |
|
|
2021
Q3 | $949K | Hold |
95,685
| – | – | 0.02% | 430 |
|
|
2021
Q2 | $951K | Buy |
+95,685
| New | +$951K | 0.03% | 355 |
|
|
2021
Q1 | – | Sell |
-17,318
| Closed | -$187K | – | 451 |
|
|
2020
Q4 | $187K | Sell |
17,318
-80,443
| -82% | -$869K | 0.01% | 152 |
|
|
2020
Q3 | $1.01M | Buy |
+97,761
| New | +$1.01M | 0.04% | 88 |
|